Read More Pharma Industry News AstraZeneca and Daiichi Sankyo win FDA approval for Enhertu combo as new standard in HER2 mBC Enhertu plus pertuzumab gets FDA approval for first-line HER2-positive mBC, setting a new standard in metastatic breast cancer care. Read what changes now. bySrinathDecember 17, 2025